Research Article

Is Diabetes mellitus a risk factor for onychomycosis and tinea pedis?

Volume: 42 Number: 3 October 27, 2020
EN

Is Diabetes mellitus a risk factor for onychomycosis and tinea pedis?

Abstract

Background Diabetes is an important disease with a frequency of 7.2% that leads to mortality and morbidity and impairs quality of life. The prevalence of skin symptoms in diabetes is 30% and a significant proportion of these are skin infections. The objective of this study was to determine the frequency of onychomycosis and tinea pedis in patients with diabetes mellitus compared to non-diabetic control group with similar age and gender, to evaluate diabetic and epidemiological risk factors, and to determine the pathogens in onychomycosis and tinea pedis. Materyal and methods A total of 167 patients followed-up for diabetes were enrolled in the study. The control group comprised 150 individuals with similar age and gender characteristics with the diabetic group. The demographic data for each subject were recorded in a questionnaire form by face-to-face interview with the consent of the patient. Data recorded in this questionnaire included age, gender, type and duration of diabetes, and hemoglobin A1c (HbA1C) levels. Clinical samples were collected separately from the toenails and the surrounding area and from the plantar and interdigital area of the feet for direct microscopic examination and culture. Results The co-occurrence of diabetes and tinea pedis was significantly increased in this study. T. rubrum growth was seen in a substantial proportion of the cases and intertriginous type was the most frequently observed type, similar to normal population. In this study, the correlation between diabetes types and onychomycosis or tinea pedis was not significant while longer duration of diabetes was found to increase susceptibility to fungal infections. Conclusion It was concluded that the frequency of onychomycosis and tinea pedis, as an important cause of morbidity in diabetes, should routinely be surveyed, any infections should be treated, and patients should be given training regarding the protective measures and risk factors.

Keywords

References

  1. 1. Perez MI, Kohn SR. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 1995; 32(4): 143-144.
  2. 2. Bouguerra R, Essais O, Sebai N, Ben Salem L, Amari H, Kammoun MR,et all. Prevalence and clinical aspects of superficial mycosis in hospitalized diabetic patients in Tunisia. Med Mal Infect 2004; 34(5): 201-205.
  3. 3. Tan JS, Joseph WS. Common fungal infections of the feet in patients with diabetes mellitus. Drugs Aging 2004; 21(2): 101-112.
  4. 4. Somolinos AL, Sànchez JL. Prevalence of dermatophytosis in patients with diabetes. J Am Acad Dermatol 1992; 26: 408-410.
  5. 5. Dogra S, Kumar B, Bhansali A, Chakrabarty A. Epidemiology of onychomycosis in patients with diabetes mellitus in India. International Journal of Dermatology 2002; 41: 647-651.
  6. 6. Aşçı Z, Seyrek A, Kizirgil A, Yılmaz M. Diyabetli hastalarda tinea unguium araştırılması. Turkish Journal of Infection 1996; 10(4): 365-367.
  7. 7. Oz Y,Oz A, Qoaraan I, Balta I. Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey Int J Dermatol. 2017 Jan;56(1):68-74
  8. 8. Sert M,İlkit M,Tetiker T et all. Diabetes mellitus ve ayak dermatomkozları: gerçekten ilişkili mi? Turkısh Journal of Infection 2001;15(3):341-43

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

October 27, 2020

Submission Date

August 24, 2020

Acceptance Date

October 27, 2020

Published in Issue

Year 2020 Volume: 42 Number: 3

AMA
1.İnan Doğan E, Karakaş M. Is Diabetes mellitus a risk factor for onychomycosis and tinea pedis? CMJ. 2020;42(3):359-365. doi:10.7197/cmj.757045

Cited By